Patent granted in Europe, USA and Canada.
MTS-SAS combines the reliability of MIC Test Strip with patented tools to facilitate and standardize a critical assay such as the in-vitro combination of antibiotics. Antimicrobial resistance is a major challenge for clinicians and clinical microbiologists, the use of synergy testing is nowadays increasingly requested. MTS-SAS procedure is significantly faster than any other methods in antibiotic synergy tests (i.e. timekill, checkerboard), does not require any additional trainings to those who are skilled in the usage of MIC Test Strip, reduces or eliminates the risks of procedure errors when compared to laborious and complicated traditional methods.
• easy to use
• save time, materials, workload, resources
FIC Index = MICAB/ MICA+ MICBA/ MICB
|MTS Synergy Application System|
|MTS Synergy Applicator Platform||1 base||96860|
|MTS Synergy Delivery Tool||10 disposable applicators||96870|
Evaluation of in-vitro activity of double beta-lactam therapy and relationship with penicillin binding proteins activity in E. coli isolates.
J. Suich, M. Van der Woude, D. Wearmouth, P. Burns, G. Barlow
ECCMID 2022, Poster 0789
Khan A, Erickson SG, Pettaway C, Arias CA, Miller WR, Bhatti MM. 2021
Evaluation of susceptibility testing methods for aztreonam and ceftazidime-avibactam combination therapy on extensively drug-resistant Gram-negative organisms.
ASM Antimicrob Agents Chemother 65:e00846-21
Evaluation of synergistic activity of plazomicin-based combinations against KPC-producing Klebsiella pneumoniae with complex multidrug resistance phenotypes
M. Iannaccone, M. Boattini, G. Bianco, R. Cavallo & C. Costa
Journal of Chemotherapy, July 2021
Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa
Marco Iannaccone, Matteo Boattini, Gabriele Bianco, Rossana Cavallo, Cristina Costa
International Journal of Antimicrobial Agents, July 2020
Evaluation of the in vitro activity of WCK 5222 (cefepime/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: Expanding the zone of hope
L. M. Avery , E. M. Mullane , D. P. Nicolau
International Journal of Antimicrobial Agents, Volume 55, Issue 2, February 2020, 105863
Importance of "in vitro" synergism examinations on infections caused by multidrug-resistant pathogens
M. Knausz, A. Becker, R. Nikolova, E. Urbaán, A. Laázaár
Multicentric evaluation of the reliability and the reproducibility of synergy testing using the MIC test strip - synergy application system (MTS-SAS™)
E. Carretto, F. Brovarone, P. Gaibani, G. Russello, C. Farina
Efficacy of Fosmidomycin alone and in combination with colistin, tigecycline and rifampicin against multi-drug resistant and extensively drug resistant Enterobacteriaceae
J. Tyrrell, T. R. Walsh
ECCMID 2014, Poster no. 235
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
H. Schemuth, S. Dittmer, M. Lackner, L. Sedlacek, A. Hamprecht, E. Steinmann, J. Buer, P.-M. Rath and J. Steinmann
Mycoses, 2013, 56, 297–303
Evaluation of gradient concentration strips for in vitro combination testing of antifungal combinations against Candida spp.
M. Siopi, A. Elefanti, N. Siafakas, L. Zerva, J. Meletiadis
ECCMID 2013, poster no. 976
Synergistic effects of rifampicin, nitrofurantoin, fosfomycin and colistin against NDM-1 positive Klebsiella pneumoniae and Escherichia coli using the new MTS synergy method
J. Weeks, T. R. Walsh
ECCMID 2013, poster no. 1553